🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Mohini Ranganathan

Yale University

ORCID: 0000-0002-8412-2923

Also affiliated with VA Connecticut Healthcare System, Gobierno de Canarias

MedicinePharmacology, Toxicology and PharmaceuticsNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia”.

Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia

Schizophrenia Research(2023)10.1016/j.schres.2023.04.010

N/A

0.473DataRank · unranked

9 citations

Mohini Ranganathan, Jason Johannesen, Ralitza Gueorguieva, Emma Deaso, Joshua Kenney +3 more

Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior

Cannabis and Cannabinoid Research(2022)10.1089/can.2021.0166

N/A

0.184DataRank · unranked

2 citations

Jose Cortes-Briones, Ashley M. Schnakenberg Martin, Patrick D. Skosnik, Deepak Cyril D’Souza, Mohini Ranganathan +1 more

Alterations in the Endocannabinoid System in Schizophrenia

Biological Psychiatry(2020)10.1016/j.biopsych.2020.08.019

N/A

0DataRank · unranked

2 citations

Deepak Cyril D’Souza, Mohini Ranganathan

A Robust and Reproducible Connectome Fingerprint of Ketamine is Highly Associated with the Connectomic Signature of Antidepressants

medRxiv(2020)10.1101/2020.04.10.20061085

N/A

0DataRank · unranked

1 citations

Kyung-Heup Ahn, Lynnette A. Averill, Samaneh Nemati, Christopher L. Averill, Samar Fouda +7 more

Age, gender and body-mass-index relationships with in vivo CB1 receptor availability in healthy humans measured with [11C]OMAR PET

NeuroImage(2022)10.1016/j.neuroimage.2022.119674

N/A

0DataRank · unranked

15 citations

Patrick D. Worhunsky, Ming‐Qiang Zheng, Soheila Najafzadeh, Jean‐Dominique Gallezot, Beata Planeta +11 more

Peripheral signature of altered synaptic integrity in young onset cannabis use disorder: A proteomic study of circulating extracellular vesicles

The World Journal of Biological Psychiatry(2023)10.1080/15622975.2023.2197039

N/A

0DataRank · unranked

8 citations

TuKiet T. Lam, Rolando García-Milian, Deepak Cyril D’Souza, Angus C. Nairn, Katya Elgert +3 more

The Potential Use of Cannabidiol in the Treatment of Opioid Use Disorder: A Systematic Review

Addiction Biology(2025)10.1111/adb.70047

N/A

0DataRank · unranked

4 citations

Kevin Ing, Yasna Rostam‐Abadi, Jeremy Weleff, Mackenzie Griffin, Mohini Ranganathan +5 more

Modulation of the antidepressant effects of ketamine by the mTORC1 inhibitor rapamycin

Neuropsychopharmacology(2020)10.1038/s41386-020-0644-9

N/A

0DataRank · unranked

181 citations

Lynnette A. Averill, Ralitza Gueorguieva, Selin Goktas, Prerana Purohit, Mohini Ranganathan +9 more

A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trial

Journal of Psychiatric Research(2025)10.1016/j.jpsychires.2025.12.020

N/A

0DataRank · unranked

0 citations

Zailyn Tamayo, Ally Price, Lining Pan, Yvette Afriyie-Agyemang, Shriya Agrawal +39 more

A robust and reproducible connectome fingerprint of ketamine is highly associated with the connectomic signature of antidepressants

Neuropsychopharmacology(2020)10.1038/s41386-020-00864-9

N/A

0DataRank · unranked

34 citations

Kyung-Heup Ahn, Lynnette A. Averill, Samaneh Nemati, Christopher L. Averill, Samar Fouda +7 more